![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07C 219/06 | |
C07C 219/08 | |||
C07C 219/10 | |||
C07C 229/16 | |||
C07D 295/13 | |||
A61K 47/50 | |||
A61K 9/127 |
(11) | Number of the document | 3160938 |
(13) | Kind of document | T |
(96) | European patent application number | 15730023.7 |
Date of filing the European patent application | 2015-06-05 | |
(97) | Date of publication of the European application | 2017-05-03 |
(45) | Date of publication and mention of the grant of the patent | 2020-09-16 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2015/034496 |
Date | 2015-06-05 |
(87) | Number | WO 2015/199952 |
Date | 2015-12-30 |
(30) | Number | Date | Country code |
201462016839 P | 2014-06-25 | US |
(72) |
ANSELL, Steven, M., CA
DU, Xinyao, CA
|
(73) |
Acuitas Therapeutics Inc.,
6190 Agronomy Road Suite 402 University of British Columbia - KETR, Vancouver, British Columbia V6T 1W5,
CA
|
(54) | NOVEL LIPIDS AND LIPID NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDS |
NOVEL LIPIDS AND LIPID NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDS |